Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Epidemiologie van COVID-19-geassocieerde pulmonale aspergillose
mrt 2022 | Schimmelinfecties, Virale infecties